Build validated 3D protein structure models from sequence, template, AlphaFold prediction or PDB information to support structure-based drug design, protein engineering, binding site analysis, molecular docking, virtual screening and molecular dynamics studies.
Compare templates, predicted models and local confidence to select the most appropriate structure for downstream analysis.
Identify binding pockets, functional residues and regions suitable for docking, inhibitor design or mutagenesis planning.
Decide whether to proceed to molecular docking, virtual screening, MD refinement, binding free energy or protein engineering.
Template search, alignment review, model generation, local refinement and model selection for targets with suitable homologous structures.
Evaluate AI-predicted structures for local confidence, biological plausibility, missing regions and downstream modeling readiness.
Prepare protein models for protein-ligand docking, PPI docking, virtual screening and MD simulation.
Locate candidate pockets and interpret residue-level features that affect ligand design, target validation and mechanism-of-action analysis.
Support challenging receptor and membrane protein projects where experimental structures are incomplete or unavailable.
Use structural models to guide mutation analysis, variant prioritization, stability assessment and experimental planning.
| Project Input | How It Is Used | Typical Deliverable | Decision Value |
|---|---|---|---|
|
Used for template search, AI prediction review, sequence alignment, structure source evaluation and model generation. |
|
Provides a usable structural basis for docking, virtual screening, protein engineering or MD simulation. |
|
Used to focus binding-site review, pocket selection, docking setup and downstream screening strategy. |
|
Supports ligand design, druggability evaluation, target validation and mechanism-of-action analysis. |
|
Used to prioritize biologically relevant regions, interpret structural risks and guide variant analysis. |
|
Helps determine whether the model is reliable enough for mutagenesis, engineering or validation planning. |
|
Used to select the appropriate modeling depth, preparation workflow, refinement strategy and output format. |
|
Guides the next step toward docking, MD refinement, binding free energy analysis or experimental validation. |
Review sequence, PDB/template availability, target class, known functional residues and the desired downstream use.
Assess templates, AlphaFold models, homologous structures and modeling methods before selecting the best strategy.
Build and refine one or more candidate structures with attention to active sites, loops, interfaces and relevant domains.
Evaluate model reliability, local confidence, pocket geometry, functional residues and downstream readiness.
Deliver files, visualization and a practical recommendation for docking, MD, virtual screening or experimental validation.
Input: Protein sequence, target family and planned docking workflow.
Output: Modeled and prepared structure, pocket review and docking-readiness recommendation.
Input: Receptor sequence, template information and known ligand or binding-site notes.
Output: GPCR model, binding pocket interpretation and virtual-screening preparation guidance.
Input: Protein model, mutation list, assay notes or desired stability/function objective.
Output: Structural interpretation of mutation regions and recommended next-step validation workflow.
Typical inputs include amino acid sequence, known PDB structures or templates, AlphaFold models if available, target family information, ligand or substrate information, known mutations and the intended downstream use such as docking, virtual screening or molecular dynamics.
The model can be prepared as a docking-ready structure with quality assessment, binding pocket review, structure preparation notes and recommendations for molecular docking, virtual screening or molecular dynamics simulation.
Yes. Existing AlphaFold or predicted models can be reviewed for local confidence, missing regions, pocket suitability, biological plausibility and readiness for docking, screening or MD simulation.
No. This is an expert-led computational biology service, not a free software package. The service includes project design, model generation, validation, interpretation and technical reporting.
Submit your project details below, and our team will respond within 24 hours.
Talk to our technical team about your project!
I Want To Talk